Recurrent Lung Non Squamous Non Small Cell Carcinoma

AUG 19, 2026 · PHASE 3 TRIAL

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registration with no posted results; the study is actively recruiting and outcome data are not yet available for analysis.

AUG 4, 2026 · PHASE 2 TRIAL

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

ClinicalTrials.gov

This is an active Phase 2 trial registration with no results posted; the study design and rationale are described but no efficacy or safety outcomes are reported.